T1	Disease 63 76	Breast Cancer
T2	Disease 442 455	breast cancer
T3	OrganismPart 7330 7335	Tumor
T4	FractionationMethod 7855 7884	strong anion exchange columns
T5	NumberOfSamples 6062 6101	set 1: 21 samples and set 2: 24 samples
T6	Sex 8617 8622	women
T7	Disease 8628 8649	primary breast cancer
T8	FactorValue 9709 9730	normal breast tissues
T9	FactorValue 442 455	breast cancer
T10	NumberOfSamples 8507 8509	21
T11	NumberOfSamples 10130 10132	24
T12	CleavageAgent 13671 13678	trypsin
T13	CleavageAgent 15051 15058	trypsin
T14	ReductionReagent 15272 15286	dithiothreitol
T15	AlkylationReagent 15837 15850	iodoacetamide
T16	CleavageAgent 16035 16042	trypsin
T17	FractionationMethod 16326 16347	strong anion-exchange
T18	FractionationMethod 16633 16636	SAX
T19	FractionationMethod 16611 16631	trong anion-exchange
*	Equiv T19 T18
T20	FractionIdentifier 16955 16972	8, 6, 5, 4, and 3
T21	Instrument 18245 18260	Q-Exactive Plus
T22	Chromatography 18487 18522	EASY-nLC 1000 liquid chromatography
T23	NumberOfFractions 18638 18639	6
T24	FragmentationMethod 19002 19046	higher energy induced collision dissociation
T25	FragmentationMethod 19048 19051	HCD
*	Equiv T24 T25
T26	Instrument 19322 19337	Q-Exactive HF-X
T27	Chromatography 19628 19641	EASY-nLC 1200
T28	FragmentationMethod 20227 20230	HCD
T29	Organism 20628 20633	human
T30	Label 20683 20708	Label-free quantification
T31	Label 20710 20713	LFQ
*	Equiv T30 T31
T32	CleavageAgent 20783 20790	trypsin
T33	Modification 20885 20912	carbamidomethylation of Cys
A1	Modification T33 fixed
T34	PrecursorMassTolerance 20948 20962	20 and 4.5 ppm
T35	Modification 21030 21067	acetylation of the N-terminal residue
A2	Modification T35 variable
T36	Modification 21069 21085	oxidation of Met
A3	Modification T36 variable
T37	AcquisitionMethod 16212 16215	DDA
T38	AcquisitionMethod 18210 18213	DDA
T39	AcquisitionMethod 18551 18554	DDA
T40	AcquisitionMethod 19281 19284	DIA
T41	AcquisitionMethod 20443 20446	DDA
T42	AcquisitionMethod 20466 20469	DDA
T43	AcquisitionMethod 21399 21402	DIA
